Abstract
Sarcoidosis or sarcoid-like reaction can occur or manifest several years after completion of treatment during the long-term follow-up of malignant tumors, often creating difficulty in differentiating these lesions from recurrent or metastatic malignant tumors on imaging studies. In recent years, CT and positron-emission tomography (PET) have been widely used in follow-up of malignant tumors; and findings in these studies are similar for sarcoidosis/sarcoid-like reaction and recurrent/metastatic diseases, special caution is needed in diagnosing either of these disorders. In patients who show results incompatible with recurrent or metastatic disease clinically and in imaging studies, even if increased FDG uptake on PET images is noted, biopsy should be performed, thereby allowing unnecessary treatments to be avoided.
References
Diagnostic Standard and Guideline for Sarcoidosis—2006 (2007) JJSOG 27:95–102
Cohen PR, Kurzrock R (2007) Sarcoidosis and malignancy. Clin Dematol 25:326–333
Brincker H (1986) Sarcoid reactions in malignant tumors. Cancer Treat Rev 3:147–156
Hunsaker AR, Munden RF, Pugatch RD et al (1996) Sarcoidlike reaction in patients with malignancy. Radiology 200:255–261
Hunt BM, Vallieres E, Buduhan G et al (2009) Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg 197:629–632
Chowdhury FU, Sheerin F, Bradley KM et al (2009) Sacoid-like reaction to malignancy on wholebody integrated 18F-FDG PET/CT:prevalence and disease pattern. Clin Radiol 64:675–681
Maeda A, Ohta M, Hirabayashi H et al (2005) False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer. Jpn J Thorac Cardiovasc Surg 53:196–198
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Fujiwara, K., Hasegawa, H., Nishikawa, T. et al. Sarcoidosis or sarcoid-like reaction developed during the follow-up of malignant tumors: difficulties in differentiation from recurrent or metastatic diseases. Int Canc Conf J 3, 220–226 (2014). https://doi.org/10.1007/s13691-014-0151-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-014-0151-0